Angiodynamics, inc. (ANGO)
Income statement / Quarterly
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14Aug'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11May'11Feb'11Nov'10Aug'10
Net sales

69,780

70,003

66,042

71,182

65,524

69,985

63,943

5,687

83,851

86,706

85,411

7,059

85,602

89,029

88,098

93,419

87,434

89,284

83,753

90,697

86,597

92,149

87,091

94,060

88,150

88,571

83,644

89,932

81,571

87,007

83,406

57,820

51,567

58,099

54,431

56,223

54,648

53,372

51,507

Cost of sales (exclusive of intangible amortization)

29,481

28,459

27,825

29,850

27,361

29,433

27,990

-8,761

38,403

43,975

44,182

-3,057

41,810

44,019

43,066

51,892

43,900

43,400

40,382

45,366

48,924

45,321

41,127

46,144

43,357

43,686

41,064

46,166

40,370

42,919

43,947

27,302

22,153

24,868

22,285

23,797

22,927

21,836

21,487

Gross profit

40,299

41,544

38,217

41,332

38,163

40,552

35,953

14,448

45,448

42,731

41,229

10,116

43,792

45,010

45,032

41,527

43,534

45,884

43,371

45,331

37,673

46,828

45,964

47,916

44,793

44,885

42,580

43,766

41,201

44,088

39,459

30,518

29,414

33,231

32,146

32,426

31,721

31,536

30,020

Operating expenses:
Research and development

8,395

7,764

6,292

6,893

6,915

7,076

7,374

5,333

6,457

6,107

6,441

5,575

5,951

5,913

6,709

6,937

5,808

6,179

6,129

6,552

6,578

6,276

7,188

7,367

7,045

7,003

6,709

6,438

5,793

7,014

7,074

5,221

4,574

5,125

5,591

5,550

5,322

5,259

5,242

Sales and marketing

20,934

20,113

19,380

20,776

18,385

19,263

18,405

16,731

18,009

18,967

19,402

16,523

19,418

19,469

19,455

20,210

20,955

21,378

21,200

20,281

19,799

21,536

20,735

23,569

20,700

21,073

19,963

20,387

18,520

18,671

18,543

16,548

15,802

15,847

16,308

15,333

14,553

13,793

14,444

General and administrative

10,203

10,994

8,453

8,487

8,718

9,262

8,435

7,672

7,723

7,540

8,056

8,042

7,051

7,839

8,201

7,686

6,901

8,082

7,914

8,317

6,613

7,786

7,315

7,360

6,445

6,411

6,686

6,331

6,046

6,910

6,899

5,662

4,434

4,625

4,312

4,723

4,346

4,173

4,586

Amortization of intangibles

5,000

4,500

3,900

4,500

4,700

4,500

3,400

1,504

4,200

4,100

4,096

1,714

4,360

4,291

4,235

4,608

4,458

4,483

4,415

4,730

5,188

4,011

4,037

3,904

4,248

4,339

4,109

4,459

4,314

4,107

3,737

2,394

2,320

2,300

2,295

2,573

2,252

2,142

2,267

Change in fair value of contingent consideration

419

145

-448

-7,641

609

244

12

32

31

82

105

125

122

-15,951

443

318

-31

306

355

430

-9,794

542

726

573

-4,154

940

733

-

630

197

-

-

0

-

-

-

-

-

-

Acquisition, restructuring and other items, net

1,565

1,421

1,500

5,427

2,550

2,728

4,422

3,500

4,177

4,766

2,989

15,482

1,750

7,861

2,417

3,493

3,042

3,913

2,143

-

18,676

2,062

-

3,176

3,016

2,679

2,002

4,054

5,157

2,067

2,522

8,487

5,041

1,408

923

-

-

772

-

Medical device excise tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

435

978

1,003

-

-

-

-

874

980

999

976

-

683

-

-

-

0

-

-

-

-

-

-

Total operating expenses

46,535

44,967

39,045

38,398

41,837

43,079

42,082

34,741

40,588

41,608

41,089

45,591

38,652

29,422

41,460

43,252

41,568

45,319

43,159

44,202

48,094

43,289

43,660

46,785

38,280

43,444

41,178

43,342

41,143

38,966

38,775

38,312

32,171

29,305

29,429

34,589

26,473

26,139

26,539

Operating loss

-6,236

-3,423

-828

2,934

-3,674

-2,527

-6,129

-20,293

4,860

1,123

140

-35,475

5,140

15,588

3,572

-1,725

1,966

565

212

1,129

-10,421

3,539

2,304

1,131

6,513

1,441

1,402

424

58

5,122

684

-7,794

-2,757

3,926

2,717

-2,163

5,248

5,397

3,481

Other (expenses) income:
Interest expense, net

166

41

465

1,410

1,442

1,330

917

839

740

760

723

683

627

810

719

778

809

998

800

-

-

-

-

534

917

959

1,246

1,285

1,271

1,383

1,332

179

102

111

116

140

119

116

124

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

1

1

-

-

-

-

0

0

0

0

0

0

21

82

290

305

260

235

201

208

161

167

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

239

-

232

474

374

409

-959

1,053

832

719

883

608

628

588

531

326

506

733

358

267

307

571

Other expense, net

-131

162

-98

-5,234

-266

80

114

-3,331

-49

-280

567

-2,851

44

-363

50

-2,703

-214

-1,236

-118

-977

-1,331

-1,166

-1,208

425

-1,970

-1,791

-1,965

-2,168

-1,879

-1,990

-1,838

-420

-123

-357

-614

-297

-178

-262

-528

Total other expense, net

-297

121

-563

-

-1,708

-1,250

-803

-

-789

-1,040

-156

-

-583

-1,173

-669

-

-1,021

-

-917

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income tax benefit

-6,533

-3,302

-1,391

1,389

-5,382

-3,777

-6,932

-21,401

4,071

83

-16

-36,170

4,557

14,415

2,903

-2,822

945

-671

-705

152

-11,752

2,373

1,096

1,556

4,543

-350

-563

-1,744

-1,821

3,132

-1,154

-8,214

-2,880

3,569

2,103

-2,460

5,070

5,135

2,953

Income tax benefit

-824

-566

-116

-1,365

-773

-190

-1,228

-941

-9,948

-166

19

-11,197

1,670

681

1,603

40,253

351

-337

70

740

-7,599

1,304

812

3,090

28

-89

-190

-277

-829

1,163

-433

-1,097

-1,112

1,240

730

-1,599

1,259

1,856

1,065

Net loss from continuing operations

-5,709

-2,736

-1,275

2,754

-4,609

-3,587

-5,704

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations, net of income tax

0

0

0

56,119

5,405

5,727

5,235

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss)

-5,709

-2,736

-1,275

58,873

796

2,140

-469

2,102

14,019

249

-35

-12,913

2,887

13,734

1,300

-43,075

594

-334

-775

-588

-4,153

1,069

284

-1,534

4,515

-261

-373

-1,467

-992

1,969

-721

-7,117

-1,768

2,329

1,373

-861

3,811

3,279

1,888

Loss per share continuing operations - basic (usd per share)

-0.15

-0.07

-0.03

0.07

-0.12

-0.10

-0.15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss per share continuing operations - diluted (usd per share)

-0.15

-0.07

-0.03

0.07

-0.12

-0.10

-0.15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income per share discontinued operations - basic (usd per share)

0.00

0.00

0.00

1.50

0.14

0.15

0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income per share discontinued operations - diluted (usd per share)

0.00

0.00

0.00

1.50

0.14

0.15

0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) per share
Basic (in usd per share)

-0.15

-0.07

-0.03

1.57

0.02

0.06

-0.01

0.05

0.38

0.01

0.00

-0.35

0.08

0.37

0.04

-1.20

0.02

-0.01

-0.02

-0.01

-0.12

0.03

0.01

-0.04

0.13

-0.01

-0.01

-0.04

-0.03

0.06

-0.02

-0.27

-0.07

0.09

0.05

-0.03

0.15

0.13

0.08

Diluted (in usd per share)

-0.15

-0.07

-0.03

1.57

0.02

0.06

-0.01

0.06

0.37

0.01

0.00

-0.35

0.08

0.37

0.04

-1.20

0.02

-0.01

-0.02

-0.01

-0.12

0.03

0.01

-0.04

0.13

-0.01

-0.01

-0.04

-0.03

0.06

-0.02

-0.27

-0.07

0.09

0.05

-0.04

0.15

0.13

0.08

Basic weighted average shares outstanding (in shares)

37,999

37,992

37,783

37,597

37,518

37,500

37,323

37,193

37,122

37,066

36,919

36,716

36,625

36,807

36,319

36,399

36,146

36,140

35,960

-

-

-

-

35,276

35,184

35,132

34,950

34,904

34,834

34,827

34,704

26,186

25,129

25,190

25,024

24,978

24,902

24,845

24,755

Diluted weighted average shares outstanding (in shares)

37,999

37,992

37,783

37,599

37,518

37,500

37,323

36,555

37,442

37,383

36,919

35,497

37,126

37,146

36,698

36,155

36,390

36,140

35,960

-

-

-

-

35,973

35,704

35,132

34,950

34,420

34,834

35,311

34,704

25,863

25,129

25,340

25,197

25,231

25,174

25,094

25,032